Measuring patient‐reported distress from breast magnetic resonance imaging: Development and validation of the MRI ‐related distress scale ( MRI ‐ DS )
Cancer Medicine · 2024
DOI: 10.1002/cam4.70089 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Cancer Medicine, 2024. Verfasst von Danbee Kang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Epidemiology, Samsung Medical Center, Seoul, South Korea. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Breast Neoplasms, Quality of Life. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Korean Society of Breast Imaging and Korean Society for Breast Screening, Bayer Korea, the Institution of Quality of Life in Cancer funded by Samsung Fire & Marine Insurance.
Abstract (Originalsprache)
Objective
Although breast magnetic resonance imaging (MRI) is a valuable screening tool, breast MRI testing burden was associated with cancer worry and quality of life. We aimed to develop and validate the MRI‐related distress scale (MRI‐DS) to assess comprehensive distress specifically related to breast MRI.
Methods
We enrolled women aged above 18 years, diagnosed breast cancer, had MRI examination at least one time, and who could speak and read Korean in phase I and enrolled women aged above 18 years, visited outpatient clinic of breast general surgery, had undergone MRI examination at least once, and could speak and read Korean in phase II. We excluded patients who had any physical or psychiatric conditions in both phases. We recruited from a tertiary university‐based hospital in South Korea between April and August 2023.
Results
All 18 items had acceptable levels of item correlation (≥0.30) in the explanatory factor analysis with a four‐factor solution. The fit indices for the four‐factor solution model were good. The discriminant validity of the MRI‐DS had a moderate correlation with general anxiety or quality of life. In the known‐group analysis, those who reported MRI as the most burden breast examination had higher total scores.
Conclusion
The validity of the MRI‐DS has been confirmed as a scale for measuring the specific distress caused by breast MRI. The MRI‐DS is recommended to health professional to communicate with patients with MRI. Clinical Implications It can be used to assess the distress associated with MRI screening in breast cancer patients. Physician could use MRI‐DS to discuss the reasons for distress caused by breast MRI screening and to address specific sources of discomfort associated with it.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Clinical Epidemiology, Samsung Medical Center, Seoul, South Korea.
- Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, South Korea.
- Cancer Education Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
- Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
- Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
ORCID-Profile: Danbee Kang, Juhee Cho
Förderung
- The Korean Society of Breast Imaging and Korean Society for Breast Screening
- Bayer Korea
- the Institution of Quality of Life in Cancer funded by Samsung Fire & Marine Insurance
Zitieren
APA
Kang, D., Kim, S., Han, J., Kim, Y., Cho, J., Lee, J. E., & Ko, E. S. (2024). Measuring patient‐reported distress from breast magnetic resonance imaging: Development and validation of the MRI ‐related distress scale ( MRI ‐ DS ). Cancer Medicine. https://doi.org/10.1002/cam4.70089
Vancouver
Kang D, Kim S, Han J, Kim Y, Cho J, Lee JE, et al. Measuring patient‐reported distress from breast magnetic resonance imaging: Development and validation of the MRI ‐related distress scale ( MRI ‐ DS ). Cancer Medicine. 2024. doi:10.1002/cam4.70089
BibTeX
@article{Kang2024,
author = {Kang, Danbee and Kim, Sooyeon and Han, Jiyoon and Kim, Youngha and Cho, Juhee and Lee, Jeong Eon and Ko, Eun Sook},
title = {Measuring patient‐reported distress from breast magnetic resonance imaging: Development and validation of the MRI ‐related distress scale ( MRI ‐ DS )},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.70089}
}
EUVIMED